The Hindu Business Line : JB Chem gets EU certification for 2 drugs

THE Rs 276-crore J.B. Chemicals & Pharmaceuticals Ltd (JBCPL), one of the domestic mid-cap pharmaceutical companies and the flagship of the Unique Group, has obtained the `Certificate of Suitability to European Pharmacopoeia Monograph' or `EP4' from the European Union (EU) for its active pharmaceutical ingredients (API) - Metronidazole and Diclofenac Sodium.

Metronidazole is currently being exported to the US, Germany, Italy, the Netherlands and Iran and sales during 2001-02 amounted to about Rs 7 crore. The company's Metronidazole manufacturing plant at Ankleshwar (Gujarat) already has US FDA and TGA Australia approval.

Exports of Diclofenac Sodium, on the other hand, constituted about 39 per cent of the drug's sales of Rs 18 crore and seven per cent of JBCPL's total sales amounting to Rs 276 crore during the same year.

JBCPL currently exports Diclofenac Sodium to Germany, Mexico, Italy and Iran.

Send this article to Friends by E-Mail
Comment on this article to BLFeedback@thehindu.co.in

Stories in this Section
Goa next in list for Sun-n-Sand — Pune operations commence

Organon (India) to shift operations to Mumbai

M.L. Narula to take over as MD of ACC

Ranbaxy to provide AIDS drugs to 10 lakh patients

SAB India changes name

One Alliance hikes rates

Accounting standards panel being reconstituted

Tribunal rejects Grasim appeal

Grasim still confident

Final report on biotech cancer drug shortly